series-b
Stage
1
Investors
About
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
Explore Repertoire Immune Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.